Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 11, 2026
Sale
Shares
234
Price
$52.21
Total Value
$12.22K
Shares Held After
50,760
% of Holdings
0.5%
Feb 11, 2026
Sale
Shares
13,950
Price
$51.61
Total Value
$719.97K
Shares Held After
50,994
% of Holdings
21.5%

INTUITIVE SURGICAL INC (ISRG)

Curet Myriam — EVP & Chief Medical Officer
Feb 11, 2026
Sale
Shares
421
Price
$494.96
Total Value
$208.38K
Shares Held After
409
% of Holdings
50.7%

INTUITIVE SURGICAL INC (ISRG)

Widman Fredrik — VP Corporate Controller
Feb 11, 2026
Sale
Shares
133
Price
$494.96
Total Value
$65.83K
Shares Held After
660
% of Holdings
16.8%

Doximity, Inc. (DOCS)

Sitaram Siddharth — Interim PFO and PAO
Feb 10, 2026
Sale
Shares
2,282
Price
$27.88
Total Value
$63.62K
Shares Held After
81,451
% of Holdings
2.7%
Feb 10, 2026
Sale
Shares
135,000
Price
$0.02
Total Value
$2.40K
Shares Held After
25,693
% of Holdings
84.0%
Feb 10, 2026
Purchase
Shares
4,000,000
Price
$0.50
Total Value
$2.00M
Shares Held After
6,779,440
% of Holdings
59.0%
Feb 10, 2026
Purchase
Shares
10,200
Price
$9.92
Total Value
$101.22K
Shares Held After
171,957
% of Holdings
5.9%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Feb 10, 2026
Sale
Shares
100
Price
$104.76
Total Value
$10.48K
Shares Held After
122,824
% of Holdings
0.1%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Feb 10, 2026
Sale
Shares
700
Price
$103.68
Total Value
$72.57K
Shares Held After
122,924
% of Holdings
0.6%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Feb 10, 2026
Sale
Shares
1,913
Price
$102.66
Total Value
$196.38K
Shares Held After
123,624
% of Holdings
1.5%
Feb 10, 2026
Purchase
Shares
521,739
Price
$5.75
Total Value
$3.00M
Shares Held After
11,931,839
% of Holdings
4.4%
Feb 10, 2026
Sale
Shares
6,622
Price
$18.12
Total Value
$119.99K
Shares Held After
351,611
% of Holdings
1.8%
Feb 10, 2026
Purchase
Shares
14,124
Price
$17.89
Total Value
$252.68K
Shares Held After
14,124
% of Holdings
100.0%
Feb 10, 2026
Sale
Shares
182,295
Price
$0.82
Total Value
$148.77K
Shares Held After
4,803,275
% of Holdings
3.7%
Feb 10, 2026
Sale
Shares
161,422
Price
$0.82
Total Value
$131.74K
Shares Held After
4,253,298
% of Holdings
3.7%

Neuronetics, Inc. (STIM)

MACAN WILLIAM ANDREW — EVP, CLO and CS
Feb 10, 2026
Sale
Shares
3,485
Price
$1.55
Total Value
$5.40K
Shares Held After
687,681
% of Holdings
0.5%
Feb 10, 2026
Sale
Shares
40,976
Price
$1.55
Total Value
$63.51K
Shares Held After
1,567,012
% of Holdings
2.5%

QUEST DIAGNOSTICS INC (DGX)

Plewman Patrick — SVP for Diagnostic Services
Feb 10, 2026
Sale
Shares
5,662
Price
$204.00
Total Value
$1.16M
Shares Held After
15,381
% of Holdings
26.9%
Shares
110
Price
$45.00
Total Value
$4.95K
Shares Held After
12,546
% of Holdings
0.9%
Feb 10, 2026
Sale
Shares
5,960
Price
$72.27
Total Value
$430.75K
Shares Held After
4,498,447
% of Holdings
0.1%
Feb 10, 2026
Sale
Shares
14,040
Price
$71.80
Total Value
$1.01M
Shares Held After
4,504,407
% of Holdings
0.3%
Feb 10, 2026
Sale
Shares
5,799
Price
$72.28
Total Value
$419.17K
Shares Held After
695,686
% of Holdings
0.8%
Feb 10, 2026
Sale
Shares
14,201
Price
$71.80
Total Value
$1.02M
Shares Held After
701,485
% of Holdings
2.0%

Sagimet Biosciences Inc. (SGMT)

Rozek Elizabeth — Chief Legal & Admin. Officer
Feb 10, 2026
Sale
Shares
2,622
Price
$5.36
Total Value
$14.05K
Shares Held After
190,959
% of Holdings
1.4%

Sagimet Biosciences Inc. (SGMT)

Martins Eduardo Bruno — Chief Medical Officer
Feb 10, 2026
Sale
Shares
3,640
Price
$5.36
Total Value
$19.51K
Shares Held After
103,296
% of Holdings
3.4%

Sagimet Biosciences Inc. (SGMT)

Chauche Thierry — Chief Financial Officer
Feb 10, 2026
Sale
Shares
1,312
Price
$5.36
Total Value
$7.03K
Shares Held After
15,688
% of Holdings
7.7%
Feb 10, 2026
Sale
Shares
12,101
Price
$5.36
Total Value
$64.86K
Shares Held After
677,621
% of Holdings
1.8%
Feb 10, 2026
Sale
Shares
752
Price
$13.79
Total Value
$10.37K
Shares Held After
26,597
% of Holdings
2.7%

Schrödinger, Inc. (SDGR)

Lorton Kenneth Patrick — EVP, CTO & COO, Software
Feb 10, 2026
Sale
Shares
925
Price
$13.73
Total Value
$12.70K
Shares Held After
52,651
% of Holdings
1.7%

Schrödinger, Inc. (SDGR)

Tran Yvonne — EVP, CLO & CPO
Feb 10, 2026
Sale
Shares
776
Price
$13.80
Total Value
$10.71K
Shares Held After
22,859
% of Holdings
3.3%
Feb 10, 2026
Sale
Shares
91
Price
$276.79
Total Value
$25.19K
Shares Held After
2,696
% of Holdings
3.3%
Feb 10, 2026
Purchase
Shares
2,434
Price
$10.27
Total Value
$25.00K
Shares Held After
582,072
% of Holdings
0.4%

Lyell Immunopharma, Inc. (LYEL)

Bulis Veronica Sanchez — VP, Corporate Controller
Feb 10, 2026
Sale
Shares
254
Price
$23.12
Total Value
$5.87K
Shares Held After
15,637
% of Holdings
1.6%

Lyell Immunopharma, Inc. (LYEL)

Lee Gary K. — Chief Scientific Officer
Feb 10, 2026
Sale
Shares
147
Price
$23.12
Total Value
$3.40K
Shares Held After
18,609
% of Holdings
0.8%

Lyell Immunopharma, Inc. (LYEL)

Hill Stephen J. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
109
Price
$23.12
Total Value
$2.52K
Shares Held After
19,031
% of Holdings
0.6%
Feb 10, 2026
Sale
Shares
438
Price
$23.12
Total Value
$10.13K
Shares Held After
81,721
% of Holdings
0.5%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 10, 2026
Sale
Shares
20,000
Price
$23.52
Total Value
$470.40K
Shares Held After
43,298
% of Holdings
31.6%

Fortrea Holdings Inc. (FTRE)

Morais Mark A. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
590
Price
$14.11
Total Value
$8.32K
Shares Held After
58,052
% of Holdings
1.0%

Fortrea Holdings Inc. (FTRE)

Morais Mark A. — Chief Operating Officer
Feb 10, 2026
Sale
Shares
589
Price
$13.65
Total Value
$8.04K
Shares Held After
58,642
% of Holdings
1.0%

Fortrea Holdings Inc. (FTRE)

Mcconnell Jill G. — Chief Financial Officer
Feb 10, 2026
Sale
Shares
441
Price
$14.11
Total Value
$6.22K
Shares Held After
59,574
% of Holdings
0.7%

Fortrea Holdings Inc. (FTRE)

Mcconnell Jill G. — Chief Financial Officer
Feb 10, 2026
Sale
Shares
440
Price
$13.65
Total Value
$6.01K
Shares Held After
60,015
% of Holdings
0.7%

BIODESIX INC (BDSX)

Pestano Gary Anthony — Chief Development Officer
Feb 10, 2026
Sale
Shares
540
Price
$10.08
Total Value
$5.45K
Shares Held After
9,387
% of Holdings
5.4%

BIODESIX INC (BDSX)

Hutton Scott — Director
Feb 10, 2026
Sale
Shares
3,559
Price
$10.08
Total Value
$35.89K
Shares Held After
45,413
% of Holdings
7.3%

BIODESIX INC (BDSX)

O'Kane Kieran — Chief Commercial Officer
Feb 10, 2026
Sale
Shares
584
Price
$10.08
Total Value
$5.89K
Shares Held After
8,885
% of Holdings
6.2%

BIODESIX INC (BDSX)

Cowie Robin Harper — CFO, Sec'y & Treasurer
Feb 10, 2026
Sale
Shares
941
Price
$10.08
Total Value
$9.49K
Shares Held After
15,297
% of Holdings
5.8%

BIODESIX INC (BDSX)

Vazquez Chris — Chief Accounting Officer
Feb 10, 2026
Sale
Shares
101
Price
$10.08
Total Value
$1.02K
Shares Held After
1,234
% of Holdings
7.6%
Feb 10, 2026
Sale
Shares
7,020
Price
$52.17
Total Value
$366.25K
Shares Held After
64,944
% of Holdings
9.8%
Feb 10, 2026
Sale
Shares
50,994
Price
$51.76
Total Value
$2.64M
Shares Held After
71,964
% of Holdings
41.5%

Tectonic Therapeutic, Inc. (TECX)

Lochner Daniel — Chief Financial Officer
Feb 10, 2026
Purchase
Shares
6,000
Price
$21.61
Total Value
$129.66K
Shares Held After
32,044
% of Holdings
18.7%
Version: v26.3.33